How to take 2.5 mg Mounjaro: what to expect from your first pen

How exactly do you use the 2.5 mg KwikPen?

The Mounjaro KwikPen is a pre-filled, multi-dose device. Each pen holds enough medication for four weekly injections at the 2.5 mg dose. You do not need to draw up a syringe or calculate anything; the pen is set to your dose from the outset.

Clean the injection site with an alcohol swab and let it dry. Pinch the skin gently if you are injecting into your abdomen or thigh, hold the pen firmly against the skin at a right angle, and press the injection button until you hear a click and the grey plunger has moved fully. Keep the pen held in place for a few seconds before removing it. Dispose of used needles in a sharps container immediately, never recap.

Rotate injection sites each week. Abdomen, outer thigh, and upper arm are the three licensed sites. Staying too long in one spot can cause localised skin changes over time. The NHS tirzepatide page covers injection technique in plain language and is worth reading alongside your Patient Information Leaflet, which remains the definitive guide for your specific pen.

Choose a day of the week you can stick to consistently, a weekly reminder on your phone works well for most people. If the same day every week doesn't fit neatly, you can shift it by a day or two as long as at least 72 hours pass between doses. For the full rules on timing gaps and what to do if you miss an injection, see the guidance on taking subsequent doses of Mounjaro.

What side effects are normal during the first four weeks?

The 2.5 mg dose exists specifically to reduce the likelihood of side effects during adjustment. Even so, some people notice nausea, mild stomach discomfort, tiredness, or loose stools in the days following their first injection. These effects are usually at their strongest in the first day or two after each dose and tend to ease as the weeks go on.

Eating smaller, lighter meals and avoiding very fatty or rich food in the 24 hours after an injection can help. Staying well hydrated matters too, nausea is harder to manage when you're already under-drinking. Most people find the GI symptoms settle considerably by weeks three and four.

A minority of people experience injection-site redness, itching, or a small lump at the injection site. Rotating your sites as described above is the best prevention. If a site becomes very painful, swollen, or shows signs of infection, contact your prescriber or GP promptly.

More serious but less common effects include symptoms of pancreatitis: severe, persistent stomach pain that spreads to the back. If this happens, stop the injection and seek urgent medical attention. The MHRA issued a Drug Safety Update for GLP-1 medicines in January 2026 specifically highlighting acute pancreatitis as a known, though infrequent, risk, worth knowing about before you start.

You can report any suspected side effects directly to the MHRA at yellowcard.mhra.gov.uk.

How long do you stay on the 2.5 mg dose, and what happens next?

Most people use the 2.5 mg pen for four weeks, one full pen. After that, your prescriber will typically move you to the 5 mg dose, provided you have tolerated the starter pen without significant problems. That next step is where the treatment begins to have a more meaningful effect on appetite and weight.

Titration is not automatic. At nume, a clinician reviews your repeat order before it is approved, which means you will not be moved to a higher dose without someone checking in. If the 2.5 mg pen caused significant side effects, it is sometimes appropriate to stay at the starter dose for another four weeks to let your body settle further, this is a clinical decision, not one to make unilaterally.

If you are curious about how long most people stay at 2.5 mg, or want to understand what the full titration ladder looks like over time, our Mounjaro treatment overview covers the licensed schedule in full. Some people also want to know about the so-called golden dose (the dose at which weight loss tends to feel most consistent) which is a different conversation, but a useful one for planning ahead.

The 2.5 mg starter pen is also available as part of the 5 mg pen at a lower injection volume, if that applies to your supply, the technique is covered separately in the guide to taking the 2.5 mg dose from a 5 mg pen.

Is there anything else to be aware of before your first injection?

A few practical things our prescribers flag regularly. First: the pen must have been refrigerated properly before use. If your pen has been left at room temperature, check the Patient Information Leaflet before injecting, there is a defined window, and exceeding it means the pen should not be used. This is one of the reasons num's GPhC-registered pharmacy uses cold-chain tracked delivery, so the pen arrives in the right condition.

Second: if you take an oral contraceptive pill, MHRA and NHS guidance advises adding a non-oral method of contraception for the first four weeks of Mounjaro treatment and for four weeks after each dose increase. Tirzepatide slows gastric emptying, which can affect how reliably the pill is absorbed. This is not a reason to avoid Mounjaro; it is a reason to plan ahead and mention it to your prescriber at consultation.

Third: tell your GP and any other healthcare professionals you see that you are taking tirzepatide. This matters particularly before any surgical procedure, anaesthetists need to know. A note on your Summary Care Record via GP notification (which forms part of the clinical process at nume) helps ensure your wider care team is in the picture.

For a broader look at how Mounjaro compares across the dose range, the 5 mg Mounjaro guide is the natural next read. And if you would like to understand private prescription costs before committing, our Mounjaro pricing page sets out what a transparent private prescription actually covers. When you are ready, you can start your free consultation with a GPhC-registered prescriber at your own pace.